![Ryan Barrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Barrett
Voorzitter bij
GABA Therapeutics, Inc.
Vermogen: 702 449 $ op 31-05-2026
Profiel
Ryan Barrett is currently Chairman at GABA Therapeutics, Inc., Director at Perception Neuroscience, Inc., Director at Recognify Life Sciences, Inc., and will be Chief Legal & Business Officer at Atai Beckley, Inc. starting in 2025.
Former roles include Director at IntelGenx Technologies Corp.
from 2023 to 2024, VP & Senior Corporate Counsel at OvaScience, Inc., Vice President- Corporate Development at Vertero Therapeutics, Inc., and Secretary & Vice President-Corporate Development at Atai Beckley NV.
Education includes undergraduate studies at Trinity College (Connecticut) and graduate studies at Case Western Reserve University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,04% | 01-10-2025 | 155.066 ( 0,04% ) | 702 449 $ | 31-05-2026 |
Actieve functies van Ryan Barrett
| Bedrijven | Functie | Begin |
|---|---|---|
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Directeur/Bestuurslid | - |
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Directeur/Bestuurslid | - |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Voorzitter | - |
Eerdere bekende functies van Ryan Barrett
| Bedrijven | Functie | Einde |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Directeur/Bestuurslid | 17-05-2024 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Corporate Officer/Principal | - |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Corporate Officer/Principal | - |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Algemeen Adviseur | - |
Opleiding van Ryan Barrett
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Trinity College (Connecticut)
 Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of new fertility treatment options for women | Health Technology |
Case Western Reserve University School of Law
 Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Health Services |
GABA Therapeutics, Inc.
GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for cognitive impairment associated with schizophrenia | Commercial Services |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Kies MarketScreener 
